Oxytocin

In simple words

Oxytocin is the brain's own hormone, often called the "bonding hormone." As a nasal spray, it is being studied as a way to increase trust and emotional closeness and to reduce social anxiety.

What this molecule is

Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂ — 9 aa nonapeptide with a Cys1-Cys6 disulfide bond. Endogenous hypothalamic neuropeptide. ~1007 Da.

Why it is studied

The "bonding hormone" — a modulator of social behavior, trust, and emotional closeness. Meta-analyses of RCTs in ASD: 5 RCTs, n=486 (2023) and 12 RCTs, n=498 (2025). RCT in neuropathic pain (intrathecal). Used for ↑emotional closeness, ↓social anxiety, and enhanced intimate sensitivity in couples.

How it works

Activates oxytocin receptors in the limbic system (amygdala, hypothalamus) → ↓amygdala activity (↓anxiety) → ↑dopamine and serotonin pathways → ↑feelings of pleasure and attachment. Rapid effect with nasal administration (5-20 min) via the olfactory pathway to the limbic system.

Doses used in studies

Studies used a nasal spray at 12–24 IU (2–4 sprays, 1 spray ≈ 6 IU) 15–30 min beforehand. Duration of effect: 45–120 min.

Combined with in studies

• PT-141 nasal — libido + emotional closeness = powerful synergy
• Kisspeptin — central activation
• Semax/Selank — ↓anxiety + ↑emotional tone
• Alcohol — NOT compatible
• Benzodiazepines — NOT compatible

Level of evidence

Level A Human clinical trials. There are randomized controlled trials (RCTs), or the compound has been approved by a regulatory agency. The most reliable level. 5+ RCTs. Meta-analyses. FDA-approved for obstetrics (other indications off-label).

Important to know

⚠️ In obesity (NEJM 2024): did not reduce weight. In autism >5 years: overall effect not significant. Data are mixed depending on the indication. Prescribed only for medical indications.

Studies in PubMed

1. Oxytocin treatment for core symptoms in children with autism spectrum disorder: a systematic review and meta-analysis. (Eur J Clin Pharmacol, 2023)
2. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial. (Mol Autism, 2023)
3. Preliminary results from a randomized, controlled, cross-over trial of intrathecal oxytocin for neuropathic pain. (Pain Med, 2023)
4. Intranasal Oxytocin for Obesity. (NEJM Evid, 2024)
5. Optimal dose of oxytocin to improve social impairments and repetitive behaviors in autism spectrum disorders: meta-analysis and dose-response meta-analysis of randomized controlled trials. (Front Psychiatry, 2024)
6. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. (N Engl J Med, 2021)